Open AccessConsensus Statement on Diagnostic End Points for Infant Tuberculosis Vaccine Trials
Author(s) -
Mark Hatherill,
Suzanne Verver,
Hassan Mahomed
Publication year - 2011
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/cir823
Subject(s) - medicine , tuberculosis , population , tuberculosis diagnosis , mycobacterium tuberculosis , clinical endpoint , disease , clinical trial , pediatrics , immunology , intensive care medicine , pathology , environmental health
Definition of clinical trial end points for childhood tuberculosis is hindered by lack of a standard case definition. We aimed to identify areas of consensus or debate on potential end points for tuberculosis vaccine trials among human immunodeficiency virus-uninfected children.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom